Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 2.000
+0.200 (11.11%)
May 8, 2026, 3:40 PM GMT
Renalytix Market Cap
Renalytix has a market cap or net worth of 7.87 million as of May 8, 2026. Its market cap has decreased by -70.31% in one year.
Market Cap
7.87M
Enterprise Value
7.57M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.00
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 7.87M, a decrease of -87.82%. That is a compound annual growth rate of -24.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 7.87M | -69.49% |
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.41B |
| GSK plc | 74.85B |
| Haleon | 29.72B |
| Smith & Nephew | 9.54B |
| Cizzle Biotechnology Holdings | 10.31M |
| CelLBxHealth | 9.66M |
| GENinCode | 9.22M |
| Oxford BioDynamics | 8.37M |